Effects of Rida in hypertension, diabetes and arthritis

A clinical trial of Rida, a polyherbal supplement, in hypertension, diabetes, and arthritis

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

PACTR

Registry ID

PACTR202011735687108

Enrollment

150

Registered

2020-11-18

Start date

2020-07-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Musculoskeletal Diseases

Interventions

Rida

Placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Aged 18-80 Diagnosed with hypertension or diabetes or arthritis

Exclusion criteria

Exclusion criteria: Presence of heart conditions Pregnancy Inability to swallow interventions by mouth Presence of major organ dysfunctions

Design outcomes

Primary

Measure	Time frame
Blood pressure;Disease activity;Plasma glucose	—

Secondary

Measure	Time frame
Biochemical and haematological parameters	—

Countries

Nigeria

Contacts

Public ContactAyodele Oyadeyi

Ladoke Akintola University of Technology

asoyadeyi@lautech.edu.ng+2348035392623

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026